Explore how to apply AI image analysis to innovate faster in precision medicine!

Are you representing a pharmaceutical company, looking for a better return on investment from your imaging trials for pulmonary drug development? Searching for solutions to explore novel measures of treatment efficacy faster, with use of AI-powered CT image analysis?

Are you in a MedTech business, working on innovations for personalized treatment of lung diseases? Interested in high-performance technology to precisely identify targeted treatment areas for pulmonary interventions, like segmentectomy, bronchoscopy, and other?

Meet our experts to address your specific questions and challenges!

4-6 September, Booth F04

Eva van Rikxoort for ERS


Eva van Rikxoort, Ph.D.
CEO & Founder

Jean-Paul Charbonnier for ERS


Jean-Paul Charbonnier, Ph.D.
Chief Innovation Officer

Professor Harm Tiddens for ERS


Prof. Harm Tiddens, MD, Ph.D.
Chief Medical Officer

Rudolfs Latisenko


Rudolfs Latisenko
Senior Deep Learning Engineer

Walter van Kuijen for ERS


Walter van Kuijen
Chief Commercial Officer

Sanaz Berahmani for ERS


Sanaz Berahmani, Ph.D.
Business Development Manager


Carla Kalkhoven
Business Development Manager

Abstract presentations of clinical validation studies with Thirona's LungQ™:

Thirona ERS abstract: Perfusion measure with HRCT-approximated perfusion is comparable to SPECT/CT for patients with severe COPD
Thirona ERS abstract: Detection of progressive airway disease on chest computed tomography in the Ataluren CF cohort using an airway-artery algorithm
Thirona ERS abstract: Effect of kernel use on emphysema score in sever COPD patients evaluated for lung volume reduction
Thirona ERS abstract: Automated airway-artery analysis on chest CT confirms positive effect of inhaled hypertonic saline in preschool children with cystic fibrosis
Thirona ERS abstract: Detection of structural airway changes on computed tomography in paediatric severe asthma